Over the last 7 days, the United States market has risen by 1.3%, contributing to a robust 28% increase over the past year, with earnings expected to grow by 17% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and may align well with current market optimism.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Uxin (UXIN) | 33.4% | 74.1% |
| Upstart Holdings (UPST) | 14.1% | 58.1% |
| OS Therapies (OSTX) | 12.4% | 72.1% |
| Laird Superfood (LSF) | 16.1% | 115.9% |
| Karman Holdings (KRMN) | 15.6% | 52.6% |
| EHang Holdings (EH) | 30.1% | 55.4% |
| Duos Technologies Group (DUOT) | 11.2% | 158.4% |
| Corcept Therapeutics (CORT) | 11.7% | 49.3% |
| Astera Labs (ALAB) | 10.1% | 31.5% |
| AppLovin (APP) | 27.4% | 21.7% |
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: First Western Financial, Inc. is a financial holding company offering wealth advisory, private banking, personal trust, investment management, mortgage lending, and institutional asset management services to individual and corporate clients with a market cap of $279.03 million.
Operations: The company generates revenue from its wealth management services, including capital management, amounting to $93.94 million and mortgage services totaling $6.52 million.
Insider Ownership: 12.8%
First Western Financial is positioned for growth with forecasted earnings expansion at 30% annually, outpacing the US market’s 16.8%. Despite no substantial insider buying recently, a share repurchase program of up to US$5 million indicates confidence in future prospects. The company reported strong Q1 results with net income rising to US$6.21 million from US$4.19 million year-over-year. However, significant insider selling raises caution regarding internal sentiment despite positive financial momentum.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Prothena Corporation plc is a late-stage clinical biotechnology company dedicated to discovering and developing novel therapies for diseases caused by protein dysregulation, with a market cap of approximately $526.67 million.
Operations: The company generates revenue primarily from its biotechnology segment, which reported $57.94 million.
Insider Ownership: 18.1%
Prothena’s revenue is forecast to grow at 31.2% annually, surpassing the US market average. The company recently reported a significant improvement in Q1 earnings, with revenue jumping to US$51.08 million from US$2.83 million year-over-year and net income turning positive at US$32.72 million. Prothena’s development of coramitug for ATTR-CM treatment, now in Phase 3 trials with Novo Nordisk, highlights its innovative pipeline despite limited recent insider trading data.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Equity Bancshares, Inc. is the bank holding company for Equity Bank, offering a variety of banking and financial services to both individual and corporate clients, with a market cap of approximately $950.92 million.
Operations: The company’s revenue is primarily generated through its banking operations, with Equity Bank contributing $280.51 million to the total.
Insider Ownership: 14.1%
Equity Bancshares is poised for robust growth, with revenue expected to rise 24% annually, outpacing the US market. Despite a decline in profit margins from 28.3% to 11.2%, insider ownership remains strong with recent buybacks and no substantial insider selling. The company trades significantly below its estimated fair value and anticipates earnings growth of over 61% per year, supported by strategic board appointments and consistent dividend payments of US$0.18 per share.
Seize The Opportunity
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders.
It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities.
All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Leave a comment